Forbes November 25, 2019
Simon Chandler

400 million people globally suffer from a rare disease. This is greater than the population of the United States, yet the ominous figures don’t end there. According to the Global Genes organization, eight out of ten rare diseases are caused by a faulty gene, yet it takes an average of 4.8 years to arrive at an accurate diagnosis. This is part of the reason why 30% of children with a rare disease won’t live to see their fifth birthday.

Neither is this situation helped by the fact that 95% of rare diseases lack an FDA-approved treatment. However, while the rarity of rare diseases means they’re often neglected by the medical establishment, artificial intelligence and machine learning have been emerging in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Precision Medicine, Provider, Technology
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Set Your Team Up to Collaborate with AI Successfully
What’s So Great About Nvidia Blackwell?
Mayo develops new AI tools
Medtronic, Tempus testing AI to find potential TAVR patients

Share This Article